Tyrvaya Spray
Product Images NDC 73521-030

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Tyrvaya (NDC 73521-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oyster Point Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure (Varenicline 01)

FDA Label Image

Tyrvaya Nasal Spray (Varenicline 02)

FDA Label Image

Remove Clip/cap (Varenicline 03)

FDA Label Image

Step 2. Hold The Nasal Spray Upright And Away From Your Face. Place One Finger On Each Side Of The Base Of The Nasal Applicator, And Place Your Thumb Underneath The Bottle. (Varenicline 04)

FDA Label Image

Press 7 Times (Varenicline 05)

FDA Label Image

Step 1. Blow Nose To Clear Nostrils If Needed. (Varenicline 06)

FDA Label Image

Remove Cap/clip (Varenicline 07)

The text suggests an action in a set of instructions where the user must remove a cap and/or a clip from a certain object. The object and the purpose of the action are not provided.*

FDA Label Image

Step 3. Hold The Nasal Spray Upright. Place One Finger On Each Side Of The Base Of The Nasal Applicator And Your Thumb Underneath The Bottle. (Varenicline 08)

FDA Label Image

Step 4. Tilt Your Head Back Slightly. (Varenicline 09)

FDA Label Image

Step 5. Insert The Nasal Applicator Into The Left Or Right Nostril. Tilt The Nasal Applicator And Aim The Tip Towards The Top Of The Ear On The Same Side. Do Not Press The Tip Of Nasal Applicator Against The Wall Of The Inside Of Your Nose. Allow For A Space Between The Tip Of Nasal Applicator And The Wall Of The Inside Of Your Nose For Proper Dose Administration. (Varenicline 0a)

FDA Label Image

Step 6. Place Tongue To The Roof Of The Mouth And Breathe Gently While Spraying 1 (one) Time. Repeat Administration In The Other Nostril. Wait 2 (two) Or 3 (three) Minutes Before Blowing Nose If Needed. (Varenicline 0b)

FDA Label Image

Step 7. Wipe The Nasal Applicator With A Clean Tissue. (Varenicline 0c)

FDA Label Image

Step 8. Replace Clip And Cap. (Varenicline 0d)

Not available.*

FDA Label Image

Diagramdescription Automatically Generated (Varenicline 0e)

This text seems to be a label of a nasal spray medication. It gives instructions for priming the spray before first use and specifies that it is for intranasal use. It also provides the lot number and expiration year of the medication. The label contains an FPO mark and a logo for Oyster Point Pharma.*

FDA Label Image

Textdescription Automatically Generated (Varenicline 0f)

Each bottle of Tyrvaya spray contains 60 sprays with varenicline tartrate as the active ingredient. The spray is used for smoking cessation purposes. It is recommended to keep the spray between 20°C to 25°C (66°F to 77°F) and not freeze it. The bottle should be discarded after 30 days from the first use. For further information, see the package insert. The product is manufactured by M. forOyste Pint Parms, Inc.*

FDA Label Image

Diagramdescription Automatically Generated (Varenicline 10)

This is a package insert label for a nasal spray which provides instructions for priming, dosing, and re-priming. It is emphasized to prime the spray before first use and avoid using it in the eyes. The label includes the product name, lot number, and expiration date. However, it does not mention the name of the medication, the manufacturer's name, or any dosage instructions, thus, further information might be needed to identify the product.*

FDA Label Image

Graphical User Interface, Text, Applicationdescription Automatically Generated With Medium Confidence (Varenicline 11)

This is a medication containing varenicline tartrate in spray form. The dosage should be followed as per the package insert. It should be stored at room temperature between 20°C to 25°C (68°Fto77°F) and should not be frozen. The bottle should be discarded after 30 days of first use. It is meant for intranasal use only. The name of the manufacturer is Oyster Paint Pharma Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.